Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum
SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.2.supp.98
Full Text
Open PDFAbstract
Available in full text
Date
December 17, 2018
Authors
Publisher
National Society for Cutaneous Medicine